#USA #AI Solutions #Veeva Systems #Clinical Trials #Pleasanton

Veeva Systems' Innovative Study Builder Agent

In a significant development for the life sciences sector, Veeva Systems has unveiled its latest technological advancement, the Veeva Study Builder Agent. This innovative AI-driven solution promises to dramatically streamline the configuration of clinical studies, enabling researchers to complete their tasks in as little as one day.

The Veeva Study Builder Agent is designed to interface seamlessly with existing Veeva tools like EDC (Electronic Data Capture) and DQS (Data Quality System). It works by interpreting study protocols and utilizing previously established organizational standards to create forms, visits, and edit check rules with exceptional efficiency.

Leveraging the CDISC Unified Study Definitions Model (USDM), the Study Builder Agent ensures that each study configuration adheres to industry standards, significantly minimizing deviations and simplifying regulatory compliance. This capability not only reduces setup time but also guarantees that the results are audit-ready from the outset, a crucial requirement for clinical trials.

Drew Garty, Chief Technology Officer at Veeva Clinical Data, highlighted the transformative potential of the Veeva Study Builder Agent, stating, "Veeva Study Builder Agent will make it much faster to build high-quality studies. We’re committed to innovations that simplify, standardize, and connect clinical trials, and Study Builder Agent is a significant step toward achieving that vision."

The agent automates various aspects of study configuration, including testing procedures by generating test data, thus further enhancing operational efficiency. With the goal of reducing the manual workload often associated with clinical trial setup, the Study Builder Agent allows clinical researchers to allocate more time towards analysis and innovation rather than administrative tasks.

Scheduled for early adopter availability in December 2026, this cutting-edge tool is included in the EDC system without requiring any additional licensing fees. The installation process is user-friendly, as it is delivered as a Claude Cowork plugin from a Veeva-managed GitHub repository.

This launch is part of Veeva’s broader commitment to enhancing clinical data management capabilities. Veeva continues to innovate and develop solutions that address the evolving challenges faced by the life sciences industry. Current and prospective users can take a closer look at Veeva’s Clinical Data solutions, inclusive of EDC, DQS, and eCOA, at the forthcoming Veeva RD and Quality Summit set to be held in Boston from October 20 to 21, exclusively open to industry professionals.

About Veeva Systems

Veeva Systems stands at the forefront of the industry cloud for life sciences, offering a suite of applications, agents, and consulting services tailored specifically for this market. Veeva's offerings support over 1,500 clients ranging from multinational pharmaceutical giants to dynamic biotech startups. As a Public Benefit Corporation, Veeva maintains a balanced approach towards the interests of multiple stakeholders including customers, employees, and shareholders.

The introduction of the Veeva Study Builder Agent underscores Veeva's dedication to fostering innovations that not only meet but exceed the demands of modern clinical research. As the landscape of clinical trials continues to evolve, such technologies will be instrumental in driving efficiency, compliance, and overall success within the life sciences domain.